Clofarabine plus cytarabine (ARA-C) combination is active in newly diagnosed patients (pts) ≥ age 50 with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).

被引：7
|
作者：
Faderl, S
Gandhi, V
Verstovsek, S
Cortes, J
Ravandi-Kashani, F
Beran, M
Garcia-Manero, G
Koller, C
O'Brien, S
Ferrajoli, A
Estrov, Z
Kwari, M
Plunkett, W
Kantarjian, HM
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Dev Therapeut, Houston, TX 77030 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.875.875
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
875
引用
收藏
页码：250A / 250A
页数：1
相关论文
共 50 条
  • [31] PHASE I/II STUDY OF VOSAROXIN AND DECITABINE IN NEWLY DIAGNOSED OLDER PATIENTS (PTS) WITH ACUTE MYELOID LEUKEMIA (AML) AND HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS)
    Daver, N.
    Kantarjian, H.
    Garcia-Manero, G.
    Jabbour, E.
    Borthakur, G.
    Pierce, S.
    Vaughan, K.
    Vaughan, K.
    Ning, J.
    Gonzalez, G.
    Pemmarjau, N.
    Kadia, T.
    Konopleva, M.
    Andreeff, M.
    DiNardo, C.
    Cortes, J.
    Ward, R.
    Craig, A.
    Ravandi, F.
    [J]. HAEMATOLOGICA, 2016, 101 : 187 - 188
  • [32] CONCOMITANT MONOCLONAL GAMMOPATHY OF UNKNOWN SIGNIFICANCE (MGUS) IN NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA (MDS/AML)
    Chen, Mingyi
    La, Hanh
    Abedi, Mehrdad
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2014, 36 : 47 - 48
  • [33] Phase II Study of the Combination of Clofarabine Plus Idarubicin and Cytarabine (CIA) In Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)
    Naqvi, Kiran
    Ravandi, Farhad
    Kantarjian, Hagop
    Borthakur, Gautam
    Ferrajoli, Alessandra
    Thomas, Deborah A.
    Koller, Charles Asa
    Konopleva, Marina
    Byrd, Anna
    Kwari, Monica
    Faderl, Stefan
    [J]. BLOOD, 2010, 116 (21) : 464 - 465
  • [34] Triapine and cytarabine is an active combination in patients with acute leukemia or myelodysplastic syndrome
    Yee, Karen W. L.
    Cortes, Jorge
    Ferrajoli, Alessandra
    Garcia-Manero, Guillermo
    Verstovsek, Srdan
    Wierda, William
    Thomas, Deborah
    Faderl, Stefan
    King, Ivan
    O'Brien, Susan M.
    Jeha, Sima
    Andreeff, Michael
    Cahill, Ann
    Sznol, Mario
    Giles, Francis J.
    [J]. LEUKEMIA RESEARCH, 2006, 30 (07) : 813 - 822
  • [35] Phase I evaluation of tipifarnib in combination with low-dose Ara-C (LDAC) in high-risk myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML): Interim results
    Cortes, J. E.
    Feldman, E. J.
    Douer, D.
    Raza, A.
    Fruchtman, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] Clofarabine, Idarubicin, and Cytarabine (CIA) As Frontline Therapy for Patients Younger Than 61 Years with Newly Diagnosed Acute Myeloid Leukemia (AML)
    Nazha, Aziz
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Jabbour, Elias
    Borthakur, Gautam
    Kadia, Tapan
    Konopleva, Marina
    Cortes, Jorge E.
    Ferrajoli, Alessandra
    Kornblau, Steven M.
    Andreeff, Michael
    Du, Min
    Brandt, Mark
    Faderl, Stefan
    [J]. BLOOD, 2011, 118 (21) : 674 - 674
  • [37] ENZYMATIC DETERMINANTS OF RESPONSE TO CYTOSINE-ARABINOSIDE (ARA-C) IN PATIENTS (PTS) WITH ACUTE MYELOID-LEUKEMIA (AML)
    RIVA, CM
    DESOUZA, G
    FERRIER, F
    MERLIN, M
    TUBIANA, N
    LEJEUNE, C
    GASTAUT, JA
    BARRA, Y
    CANO, JP
    CARCASSONNE, Y
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 502 - 502
  • [38] Autophagy induction of Acute Myeloid Leukemia (AML) cells after treatment with low dose-cytarabine (Ara-C) and enhanced cytocidal effect on AML cells by combined treatment with ara-c plus lenograstim
    Tang, Yongmin
    Li, Lixia
    Wang, Di
    Shen, Hongqiang
    Qian, Baiqin
    Luo, Chunfang
    Zhang, Haizhong
    [J]. BLOOD, 2007, 110 (11) : 114B - 114B
  • [39] Phase I trial of laromustine in combination with infusional ara-C in elderly patients over age 60 with newly diagnosed AML or high-grade MDS
    Ritchie, E. K.
    Roboz, G.
    Hinchcliff, K.
    Curcio, T.
    Scandura, J.
    Feldman, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [40] Interim results of a phase I/II randomized study of clofarabine, idarubicin, and cytarabine (CIA) versus fludarabine, idarubicin, and cytarabine (FIA) for newly diagnosed or relapsed patients (pts) with acute myeloid leukemia (AML).
    Mathisen, Michael
    Kantarjian, Hagop
    Faderl, Stefan
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Kadia, Tapan M.
    Daver, Naval Guastad
    O'Brien, Susan Mary
    Dorkhom, Stephan Joseph
    Pierce, Sherry
    Lira, Cynthia
    Cortes, Jorge E.
    Jabbour, Elias
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345